Frost & Sullivan Lauds Volpara Solutions' Quantitative Breast Imaging Tools for Driving Growth of the Breast Density Assessment Market
Volpara Solutions' Digital Health Solutions are Capable of Analyzing and Processing Large Amounts of Collected Data to Maintain Imaging Quality and Consistency
KUALA LUMPUR, Malaysia, and WELLINGTON, New Zealand, March 24, 2016 /PRNewswire/ -- Based on its recent analysis of the breast density assessment solutions market, Frost & Sullivan recognizes Volpara Solutions™ with the 2016 Global Frost & Sullivan Award for Competitive Strategy Innovation and Leadership. Volpara Solutions offers a suite of multi-vendor breast imaging tools including VolparaDensity, VolparaAnalytics, VolparaDose, and VolparaResearch. The quantitative software tools allow for personalized measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.
Volpara Solutions' technology is installed in more than 30 countries and its geographic footprint continues to expand. To date, more than 9 million women have had their breast density assessed by VolparaDensity.
VolparaAnalytics provides quality metrics and key performance indicators that let facilities evaluate their mammography and tomosynthesis system utilization, examination times, patient dose, patient positioning, and patient comfort. This can help sites correct issues that may impact the quality of the breast imaging services they deliver and help improve quality of care.
"The company believes that the more specific data it provides to the medical professional, the more it contributes to securing an accurate diagnosis for patients, and this is a driving force behind new solution developments that collect a new type of data," said Frost & Sullivan's Research Associate, Svetlana Korosteleva. "Volpara Solutions leverages modern network technologies and supporting IT deployment models. It intends to further expand its analytics capabilities by leveraging wider sets of metrics that enable it to switch to predictive healthcare, the next frontier for the healthcare industry."
"With recent pivotal research demonstrating the link between breast cancer risk and density combined with extensive validation of the ability of volumetric breast density to overcome the limitations of mammography, we have seen strong adoption for both clinical use and academic research," noted Ralph Highnam, PhD, CEO and Chief Scientist, Volpara Solutions.
Frost & Sullivan is pleased to recognize Volpara Solutions for innovative strategies in strengthening its brand and thereby, demand for its products, in the intensely competitive breast density assessment solutions market.
Each year, Frost & Sullivan presents this award to the company that has leveraged competitive intelligence to successfully execute a competitive strategy that results in stronger market share, competitive brand positioning and customer satisfaction.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Volpara Solutions
Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand (formerly Matakina Technology). Available in most markets where breast cancer screening is commonplace, VolparaDensity provides an objective volumetric measure of breast density from both digital mammography and tomosynthesis data. VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient-specific x-ray dose, breast compression, breast positioning and other factors designed to provide critical insight for breast imaging workflow. For more information, visit www.volparasolutions.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
| Contact: |
|
| Frost & Sullivan |
Volpara Solutions |
| Carrie Low |
Chris K. Joseph |
| +603.6204.5910 |
510/435-4031 |
Share this article